A Convention to Amend the Constitution, and More from CRS
Article V of the U.S. Constitution prescribes two ways by which the Constitution can be amended: Either Congress may propose amendments for ratification by the states, or else a majority of state legislatures may ask Congress to call a convention for considering amendments.
A new report by the Congressional Research Service examines the possibility of a convention to amend the Constitution. That option has never been used in practice but, CRS says, it could become newly appealing under present circumstances.
“Various contemporary developments could contribute to a renewal of congressional interest in the Article V Convention alternative,” the new CRS report said. “The emergence of Internet and social media-driven public policy and issue campaigns has combined with renewed interest in specific constitutional amendments, and the Article V Convention procedure in general, as a means of bypassing perceived policy deadlock at the federal level.”
However, “The Constitution provides only a brief description of the Article V Convention process, leaving many details that would need to be considered if a convention were to become a serious prospect.”
A copy of the new CRS report was obtained by Secrecy News. See The Article V Convention to Propose Constitutional Amendments: Contemporary Issues for Congress, July 9, 2012.
Other new and updated CRS reports that have not been approved by Congress for broad public access include the following.
Health Care: Constitutional Rights and Legislative Powers, July 9, 2012
U.S. Postal Service: Background and Analysis of H.R. 2309 and S.1789 in the 112th Congress, July 9, 2012
Conventional Prompt Global Strike and Long-Range Ballistic Missiles: Background and Issues, July 6, 2012
Criminal Prohibitions on the Publication of Classified Defense Information, June 26, 2012
Nuclear weapons budgeting is like agreeing to buying a house without knowing the sales price, the mortgage rate, or the monthly payment.
Employing a living approach to evidence synthesis, disseminated at a national level, is a streamlined way to enable evidence-based decision-making nationwide.
By providing essential funding mechanisms, the Bioeconomy Finance Program will reduce the risks inherent in biotechnology innovation, encouraging more private sector investment.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.